Vimarsana
Biggest News Aggregation in the World

Steve Audelo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Steve Audelo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Steve Audelo Today - Breaking & Trending Today

J&J, P&G Sued After FDA Panel Ruling on Cold Medicine Decongestant - Vimarsana News

J&J, P&G Sued After FDA Panel Ruling on Cold Medicine Decongestant

A new lawsuit accuses Johnson & Johnson and Procter & Gamble of having deceived consumers about decongestant cold medicines containing an

J&J, P&G, Walgreens sued after FDA panel ruling on cold medicine decongestant - Vimarsana News

J&J, P&G, Walgreens sued after FDA panel ruling on cold medicine decongestant

Johnson & Johnson, Procter & Gamble and Walgreens are among several companies accused in lawsuits of deceiving consumers about cold medicines containing an ingredient that a unanimous U.S. Food and Drug Administration advisory panel declared ineffective.

Source: ksl.com
Johnson & Johnson, Procter & Gamble sued after U.S. FDA panel ruling on cold medicine decongestant - Vimarsana News

Johnson & Johnson, Procter & Gamble sued after U.S. FDA panel ruling on cold medicine decongestant

According to a proposed class action filed in federal court, the companies knew or should have known by 2018 that their claims about products containing phenylephrine were false and misleading

J&J, P&G sued after FDA panel ruling on cold medicine decongestant - Vimarsana News

J&J, P&G sued after FDA panel ruling on cold medicine decongestant

A new lawsuit accuses Johnson & Johnson and Procter & Gamble of deceiving consumers about decongestant cold medicines containing an ingredient that a unanimous U.S. Food and Drug...

medicine: J&J, P&G sued after FDA panel ruling on cold medicine decongestant - Vimarsana News

medicine: J&J, P&G sued after FDA panel ruling on cold medicine decongestant

According to a proposed class action on Wednesday filed in Pensacola, Florida, federal court, the companies knew or should have known by 2018 that their marketing claims about products containing phenylephrine were false and misleading. That year was when new FDA guidance for evaluating symptoms related to nasal congestion demonstrated that earlier data about phenylephrine's effectiveness could no longer be relied upon, the complaint said.